Research Article

Serum Markers of Neuronal Damage and Astrocyte Activity in Patients with Chronic Epilepsy: Elevated Levels of Glial Fibrillary Acidic Protein

Table 1

Serum levels of GFAP, NSE, S100, and furin in healthy control group and patients with epilepsy.

Mann–Whitney U testMann–Whitney U test
Controls (range)
Patients (range)
valueCBZ (range)
LTG (range)
LEV (range)

GFAP (pg/ml)170 (60-15000)190 (70-15000)0.042184 (77-12335)176 (70-6809)275 (90-1500)
NSE (ng/ml)4.1 (1.9-33.7)4.4 (2.0-12.4)0.5874.6 (2.1-12.4)4.4 (2.2-12.4)4.4 (2.0-10.9)
S100B (ng/ml)130 (89-1962)119 (80-4129)0.112117 (84-4129)126 (80-914)115 (98-248)
Furin (ng/ml)0.31 (0.15-0.85)0.28 (0.4-5.00)0.5960.28 (0.13-5.0)0.34 (0.13-5.00)0.25 (0.11-0.47)

Significant value is achieved at the . GFAP: glial fibrillary acidic protein; NSE: neuron-specific enolase; S100B: S100 Ca2+-binding protein B; CBZ: carbamazepine; LTG: lamotrigine; LEV: levetiracetam; N: number. adjusted for age, sex, and BMI.